{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T21:49:31Z","timestamp":1791150571610,"version":"4.1.0"},"reference-count":20,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Indian J Pharmacol"],"published-print":{"date-parts":[[2011]]},"DOI":"10.4103\/0253-7613.77341","type":"journal-article","created":{"date-parts":[[2011,3,11]],"date-time":"2011-03-11T00:31:34Z","timestamp":1299803494000},"page":"126","source":"Crossref","is-referenced-by-count":15,"title":["Adverse drug reaction profile of nanoparticle versus conventional formulation of paclitaxel: An observational study"],"prefix":"10.4103","volume":"43","author":[{"given":"Avijit","family":"Hazra","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ballari","family":"Brahmachari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anup","family":"Majumdar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"key-10.4103\/0253-7613.77341-1","unstructured":"Chabner BA, Amrein PC, Druker BJ, Michaelson MD, Mitsiades CS, Goss PE. Antineoplastic agents. In: Brunton LL, Lazo JS, Parker, KL, editors. Goodman and Gilman\u2032s the pharmacological basis of therapeutics. 11 th ed. New York: McGraw-Hill; 2006: p. 1352-4."},{"key":"key-10.4103\/0253-7613.77341-2","first-page":"665","volume-title":"Pharmacological effects of formulation vehicles: Implications for cancer chemotherapy","author":"ten","year":"2003","journal-title":"Clin Pharmacokinet"},{"key":"key-10.4103\/0253-7613.77341-3","first-page":"735","volume-title":"Novel formulations of taxanes: A review.Old wine in a new bottle?","author":"Hennenfent","year":"2006","journal-title":"Ann Oncol"},{"key":"key-10.4103\/0253-7613.77341-4","first-page":"1263","volume-title":"Hypersensitivity reactions from taxol","author":"Weiss","year":"1990","journal-title":"J Clin Oncol"},{"key":"key-10.4103\/0253-7613.77341-5","first-page":"2486","volume-title":"Phase I clinical and pharmacokinetic study of taxol","author":"Wiernik","year":"1987","journal-title":"Cancer Res"},{"key":"key-10.4103\/0253-7613.77341-6","first-page":"1","volume-title":"Clinical toxicities encountered with paclitaxel (Taxol)","author":"Rowinsky","year":"1993","journal-title":"Semin Oncol"},{"key":"key-10.4103\/0253-7613.77341-7","first-page":"63","volume-title":"Histamine release in dogs by Cremophor EL and its derivatives: Oxethylated oleic acid is the most effective constituent","author":"Lorenz","year":"1977","journal-title":"Agents Actions"},{"key":"key-10.4103\/0253-7613.77341-8","first-page":"1332","volume-title":"Docetaxel as an alternative to paclitaxel after acute hypersensitivity reactions","author":"Bernstein","year":"2000","journal-title":"Ann Pharmacother"},{"key":"key-10.4103\/0253-7613.77341-9","first-page":"861","volume-title":"Central nervous system toxicity after liver transplantation.The role of cyclosporine and cholesterol","author":"de","year":"1987","journal-title":"N Engl J Med"},{"key":"key-10.4103\/0253-7613.77341-10","first-page":"803","volume-title":"Emulsifier for intravenous cyclosporin inhibits neurite outgrowth, causes deficits in rapid axonal transport and leads to structural abnormalities in differentiating N1E.115 neuroblastoma","author":"Brat","year":"1992","journal-title":"J Pharmacol Exp Ther"},{"key":"key-10.4103\/0253-7613.77341-11","first-page":"1","volume-title":"Novel enhanced delivery taxanes: An update","author":"Perez","year":"2007","journal-title":"Semin Oncol"},{"key":"key-10.4103\/0253-7613.77341-12","first-page":"179","volume-title":"Paclitaxel and its formulations","author":"Singla","year":"2002","journal-title":"Int J Pharm"},{"key":"key-10.4103\/0253-7613.77341-13","unstructured":"NANOXEL Injection Package Insert [Version Number IND\/00\/2006 dated December, 2006]. New Delhi: Dabur Pharma Ltd; 2006."},{"key":"key-10.4103\/0253-7613.77341-14","first-page":"793","volume-title":"Polymeric micellar delivery systems in oncology","author":"Matsumura","year":"2008","journal-title":"Jpn J Clin Oncol"},{"key":"key-10.4103\/0253-7613.77341-15","unstructured":"Common Terminology Criteria for Adverse Events v 3.0 (CTCAE). [monograph on the Internet]. United States: National Cancer Institute; 2006. Available from URL: http:\/\/www. ctep.cancer.gov\/protocolDevelopment\/electronic_applications\/docs\/ctcaev3.pdf. [accessed on 2010 Apr 7]."},{"key":"key-10.4103\/0253-7613.77341-16","unstructured":"The use of the WHO-UMC system for standardized case causality assessment [monograph on the Internet]. Uppsala: The Uppsala Monitoring Centre; 2005. Available from URL: http:\/\/www.who-umc. org\/graphics\/4409.pdf. [accessed on 2010 Apr 7]."},{"key":"key-10.4103\/0253-7613.77341-17","first-page":"188","volume-title":"Phase II study of carboplatin-paclitaxel combination chemotherapy in elderly patients with advanced non-small cell lung cancer","author":"Okamoto","year":"2005","journal-title":"Jpn J Clin Oncol"},{"key":"key-10.4103\/0253-7613.77341-18","first-page":"1846","volume-title":"Phase II study of weekly paclitaxel and cisplatin combination therapy for advanced or recurrent gastric cancer","author":"Nagata","year":"2008","journal-title":"Hepatogastroenterology"},{"key":"key-10.4103\/0253-7613.77341-19","first-page":"115","volume-title":"Motor neuropathy due to docetaxel and paclitaxel","author":"Freilich","year":"1996","journal-title":"Neurology"},{"key":"key-10.4103\/0253-7613.77341-20","first-page":"92","volume-title":"Neurotoxicity of taxanes: Symptoms and quality of life assessment","author":"Kuroi","year":"2004","journal-title":"Breast Cancer"}],"container-title":["Indian Journal of Pharmacology"],"original-title":[],"language":"en","deposited":{"date-parts":[[2026,8,13]],"date-time":"2026-08-13T15:00:12Z","timestamp":1786633212000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.4103\/0253-7613.77341"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011]]},"references-count":20,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2011]]}},"alternative-id":["77341"],"URL":"https:\/\/doi.org\/10.4103\/0253-7613.77341","relation":{},"ISSN":["0253-7613"],"issn-type":[{"value":"0253-7613","type":"print"}],"subject":[],"published":{"date-parts":[[2011]]}}}